Steven Altschuler - 02 Nov 2023 Form 3 Insider Report for Lexeo Therapeutics, Inc. (LXEO)

Role
Director
Signature
/s/ Jenny Robertson, Attorney-in-Fact
Issuer symbol
LXEO
Transactions as of
02 Nov 2023
Net transactions value
$0
Form type
3
Filing time
02 Nov 2023, 21:16:45 UTC
Previous filing
04 Oct 2023
Next filing
03 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LXEO Stock Option (right to buy) 02 Nov 2023 Common Stock 112,240 $2.33 Direct F1
holding LXEO Stock Option (right to buy) 02 Nov 2023 Common Stock 7,385 $11.02 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying the option vested on January 5, 2022, and 1/48th of the shares underlying the option vested or shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service.
F2 1/48th of the shares underlying the option vested or shall vest in monthly installments commencing on September 22, 2023, subject to the Reporting Person's continuous service.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney